Regulus Therapeutics Inc (NASDAQ:RGLS)

During the Trading Day
10.54 +0.22 / +2.13%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
10.30 -0.2439 / -2.31%
 
Volume: 2.6K
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Astrazeneca Plc
Sale11/12/20142,000,000$17.00$34.0M-47.40%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale3/05/201565,614$20.06$1.3M-51.16%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale1/28/201572,011$17.97$1.3M-41.56%
Gibson Neil W
Chief Scientific Officer
Sale1/28/201571,345$17.98$1.3M-41.56%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale4/17/201573,929$16.94$1.3M-40.35%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale4/20/201566,071$16.85$1.1M-39.93%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale4/21/201560,000$17.73$1.1M-41.43%
Alnylam Pharmaceuticals Inc
Sale10/22/201457,753$13.91$803.3K-24.95%
Isis Pharmaceuticals Inc
Sale10/22/201457,753$13.91$803.3K-24.95%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale1/29/201533,773$17.77$600.1K-44.46%
Page of 18

To view my watchlist

Not a member yet?

Sign up now for a free account